Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11302883.
- Also identified by PMC identifier 1753639.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumour necrosis factor alpha (TNFalpha) blocking agents are among the most promising new treatments for rheumatoid arthritis (RA). However, no data exist about the effect of these agents on extra-articular manifestations of RA. A patient is described with small vessel vasculitis that repeatedly responded well to treatment with the soluble p55 TNFalpha receptor fusion protein Ro 45-2081 (lenercept).
Medical subject headings
- Arthritis, Rheumatoid
- Fingers
- Immunoglobulin Heavy Chains
- Receptors, Tumor Necrosis Factor
- Recombinant Fusion Proteins
- Tumor Necrosis Factor-alpha
- Vasculitis